IWC
KYMR icon

Integrated Wealth Concepts’s Kymera Therapeutics KYMR Stock Holding History

Integrated Wealth Concepts’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72K Buy
+15
New +$1.29K ﹤0.01% 5393

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Integrated Wealth Concepts's KYMR Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 15 shares worth $1.72K. The stake represents ﹤0.01% of the portfolio and ranks #5393 among its holdings.

274 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Integrated Wealth Concepts held 15 shares of Kymera Therapeutics worth $1.72K as of Q2 2026.
  • Kymera Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5393 holding.
  • 274 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.